Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.88 USD | +1.53% | +5.74% | +1.94% |
Apr. 23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
Apr. 23 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024 |
Evolution of the average Target Price on Kiniksa Pharmaceuticals, Ltd.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Kiniksa Pharmaceuticals, Ltd.
Wedbush | |
JPMorgan Chase | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- KNSA Stock
- Consensus Kiniksa Pharmaceuticals, Ltd.